Personalizing Cardiac Medicine

Main Category: Cardiovascular / Cardiology
Article Date: 30 Jul 2008 - 2:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:4 stars

4 (1 votes)

Healthcare Prof:5 stars

5 (1 votes)


Improving patient care by "personalizing" the practice of medicine often results from studying specific drugs and their impact of genetic biomarkers.

New research underway at GW by Travis O'Brien, PhD, looks at the drug warfarin, an oral anticoagulant used to treat individuals with certain cardiovascular diseases warfarin accounts for several million prescriptions each year. With its narrow therapeutic index, warfarin may not be well tolerated by certain individuals because of their genetic makeup, says Dr. O'Brien, associate professor of Pharmacology and Physiology

O'Brien and a team of researchers hope to unlock the key to the personalization of warfarin therapy based on a patient's genetic biomarkers. The multidisciplinary research team also includes April Barbour, MD, assistant professor of Medicine, Linda Lesky, MD, associate professor of Medicine and Health Policy, and Perry Payne Jr., MD, JD, MPP, assistant research professor of Health Policy. In addition, the study will be conducted in collaboration with GW adjunct faculty, Arthur Harralson, PharmD, and Robert Kidd, PharmD, PhD, from Shenandoah University, Bernard J. Dunn School of Pharmacy.

As part of the study, samples will be collected at the Medical Faculty Associates. DNA from the samples will then be isolated and analyzed at the GW Pharmacogenomics Program laboratory, located at GW's Ashburn, Va., campus. The analyzed samples will then be subject to DNA sequencing, which is undertaking in the Department of Pharmacology and Physiology's Core Sequencing Facility located in Ross Hall.

"We believe that research aimed at decreasing the health care costs associated with stabilizing patients' wafarin dosing potentially can work as a preventative measure to decrease the incidence of adverse drug reactions associated warfarin," Dr. O'Brien said.

George Washington University
2121Eye St. NW, Rice Hall, Ste. 512
Washington, DC 20052
United States
http://www.gwu.edu

View drug information on Warfarin Sodium tablets.


Article adapted by Medical News Today from original press release.
Visit our cardiovascular / cardiology section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
George Washington University. "Personalizing Cardiac Medicine." Medical News Today. MediLexicon, Intl., 30 Jul. 2008. Web.
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/116561.php>

APA
George Washington University. (2008, July 30). "Personalizing Cardiac Medicine." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/116561.php.

Please note: If no author information is provided, the source is cited instead.




Cardiovascular / Cardiology

What Is Heart Rate?

A person's heart rate, also known as their pulse, refers to how many times their heart beats per minute. Our heart rates vary tremendously, depending on the demands we make on our bodies. Read more...

Most Popular Articles



Follow Our Cardiovascular News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Cardiovascular / Cardiology Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »